Universal Testing May Help Identify HCV in Pediatric Population
New polices, including testing for hepatitis C virus (HCV) during pregnancy, may increase HCV identification in the pediatric population by addressing gaps in maternal HCV testing.
New polices, including testing for hepatitis C virus (HCV) during pregnancy, may increase HCV identification in the pediatric population by addressing gaps in maternal HCV testing.
The U.S. Preventive Services Task Force recommends against screening for bacterial vaginosis in pregnant women not at increased preterm delivery risk.
In this interview, Jane E Salmon, MD, provides insight into the risk for COVID-19 in pregnant women with rheumatic diseases.
Three of 33 neonates born to mothers with coronavirus disease 2019 (COVID-19) in Wuhan tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers sought to evaluate the clinical characteristics of the 2019 novel coronavirus disease in pregnancy and assess transmission potential of the infection to newborns.
A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.
There are no major differences in pregnancy outcomes for women with HIV related to receipt of protease inhibitors, non-nucleoside reverse transcriptase inhibitors, or integrase strand transfer inhibitors.
Both the Revogene GBS LB and GeneXpert GBS LB assays perform well for the detection of Group B Streptococcal (GBS) infections in pregnant women.
Data published in JAMA Network Open suggest that prescribing practices of antiretroviral therapy (ART) in pregnant women living with HIV in the United States do not align optimally with national guidelines. In this prospective cohort study including data from 1867 pregnancies in 1582 women living with HIV, 49.5% were associated with prescribed ART designated as…
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.